![Jason G. Duncan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason G. Duncan
Verwaltungsdirektor bei
NEUMORA THERAPEUTICS, INC.
Profil
Mr. Jason G.
Duncan is a Chief Legal & Administrative Officer at Neumora Therapeutics, Inc. and a Software Engineer at American Panel Corp.
Mr. Duncan was previously employed as a General Counsel by Albireo Pharma, Inc., a General Counsel by Stallergenes Greer, Inc., a Vice President, Head-Compliance & Legal by Sobi, Inc., a Vice President, Head-Compliance & Legal by Swedish Orphan Biovitrum AB, and an Associate General Counsel by EMD Serono, Inc. He received his undergraduate degree from Dickinson College and a graduate degree from Suffolk University Law School.
Aktive Positionen von Jason G. Duncan
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Verwaltungsdirektor | 12.12.2023 |
American Panel Corp.
 American Panel Corp. Electronics/AppliancesConsumer Durables Manufactures freezers, warehouses, and refrigeration systems | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Jason G. Duncan
| Unternehmen | Position | Ende |
|---|---|---|
Stallergenes Greer, Inc.
 Stallergenes Greer, Inc. Pharmaceuticals: MajorHealth Technology Specializes in development and commercialization of allergy immunotherapy products for use in the diagnosis and treatment of allergies | General Counsel | 01.06.2018 |
Sobi, Inc.
 Sobi, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Swedish Orphan Biovitrum AB, Sobi, Inc. is a biopharmaceutical company that develops and provides therapies for people living with rare diseases. The company is based in Waltham, MA. The company focuses on key therapeutic areas including hematology, immunology, nephrology, and specialty care for hereditary metabolic and genetic diseases. Sobi offers a portfolio of medicines such as Alprolix®, Aspaveli®, Kineret®, Orfadin®, Tegsedi®, and others, addressing unmet medical needs in rare conditions. | Compliance Officer | 01.10.2015 |
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | 01.08.2015 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Corporate Officer/Principal | 01.07.2014 |
| ALBIREO PHARMA, INC. | General Counsel | - |
Ausbildung von Jason G. Duncan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
53
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Dickinson College
 Dickinson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Panel Corp.
American Panel Corp. Electronics/AppliancesConsumer Durables Manufactures freezers, warehouses, and refrigeration systems | Consumer Durables |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Suffolk University Law School
 Suffolk University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Stallergenes Greer, Inc.
Stallergenes Greer, Inc. Pharmaceuticals: MajorHealth Technology Specializes in development and commercialization of allergy immunotherapy products for use in the diagnosis and treatment of allergies | Health Technology |
Sobi, Inc.
Sobi, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Swedish Orphan Biovitrum AB, Sobi, Inc. is a biopharmaceutical company that develops and provides therapies for people living with rare diseases. The company is based in Waltham, MA. The company focuses on key therapeutic areas including hematology, immunology, nephrology, and specialty care for hereditary metabolic and genetic diseases. Sobi offers a portfolio of medicines such as Alprolix®, Aspaveli®, Kineret®, Orfadin®, Tegsedi®, and others, addressing unmet medical needs in rare conditions. | Commercial Services |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
